Latest CBIO reports update at 2024-05-13: 2024-Q12023-Q42023-Q1
Catalyst Biosciences logo
Catalyst Biosciences CBIO
$ 0.51 -2.65%

Catalyst Biosciences Balance Sheet 2011-2024 | CBIO

Annual Balance Sheet Catalyst Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-33.1 M -24.6 M -42 M -24.3 M -13.6 M -31.2 M -9.39 M 9.14 M 4.65 M -56.4 M -53.3 M -80.3 M -104 M

Long Term Debt

199 K 121 K 408 K 981 K - - - - - - 283 K 1.14 M 1.99 M

Long Term Debt Current

210 K 492 K 1.98 M 663 K 483 K - - - - - 853 K 851 K 1.24 M

Total Non Current Liabilities

- - - 981 K 1.32 M 174 K - 54 K 340 K - 283 K 2.32 M 5.23 M

Total Current Liabilities

20 M 12.2 M 14.2 M 17.8 M 28.9 M 4.8 M 8.74 M 22 M 37.8 M 2.34 M 11 M 11.3 M 78.6 M

Total Liabilities

38.1 M 12.5 M 14.6 M 18.8 M 30.2 M 4.98 M 8.74 M 22 M 38.1 M 2.91 M 11.3 M 13.7 M 83.8 M

Deferred Revenue

39 K 145 K 230 K 1.98 M 15 M - 212 K 283 K 438 K - - 2.36 M 57.7 M

Retained Earnings

-85.5 M 7.4 M -403 M -315 M -259 M -203 M -173 M -148 M -131 M -313 M -281 M -234 M -227 M

Total Assets

117 M 84.8 M 55.7 M 94.8 M 98.6 M 125 M 39.5 M 38.1 M 69.5 M 112 M 146 M 190 M 258 M

Cash and Cash Equivalents

33.5 M 25.2 M 44.3 M 30.4 M 15.4 M 31.2 M 14.5 M 10.3 M 29.1 M 1.54 M 2.83 M 3.4 M 107 M

Book Value

78.5 M 72.2 M 41.1 M 76.1 M 68.3 M 120 M 30.8 M 16.1 M 31.4 M 109 M 135 M 176 M 174 M

Total Shareholders Equity

-15.8 M 42.5 M 41.1 M 76.1 M 68.3 M 120 M 30.8 M 16.1 M 31.4 M -109 M -103 M -93.3 M 174 M

All numbers in USD currency

Quarterly Balance Sheet Catalyst Biosciences

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

175 K 199 K - - - - - - - 408 K 550 K 1.05 M 806 K 981 K 981 K 981 K 981 K 1.32 M 1.32 M 1.32 M 1.32 M - - - - - - - - - - - - - - - - - - - 142 K 283 K 283 K 283 K 283 K 1.14 M 1.14 M 1.14 M 1.14 M 1.99 M 1.99 M 1.99 M 1.99 M

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.12 M - - - 1.63 M - - - - - - - - - - -

Total Liabilities

33.2 M 38.1 M 6.45 M 7.4 M 11.4 M 16.8 M 1.64 M 4.31 M 13.2 M 14.6 M 17.8 M 16.6 M 15 M 18.8 M 18.8 M 18.8 M 18.8 M 30.2 M 30.2 M 30.2 M 30.2 M 4.98 M 4.98 M 4.98 M 4.98 M 8.74 M 8.74 M 8.74 M 8.74 M 22 M 22 M 22 M 22 M 38.1 M 38.1 M 38.1 M 38.1 M 3.46 M 3.46 M 2.91 M 2.91 M 3.64 M 11.3 M 11.3 M 11.3 M 13.7 M 13.7 M 13.7 M 13.7 M 83.8 M 83.8 M 83.8 M 83.8 M

Deferred Revenue

35 K 39 K - - - - - - - 230 K 853 K 2.04 M 1.33 M 1.98 M 1.98 M 1.98 M 1.98 M 15 M 15 M 15 M 15 M - - - - 212 K 530 K 848 K 259 K 283 K 283 K 283 K 283 K 438 K 438 K 438 K 438 K 1.75 M 1.75 M 25 K 61 K 1.19 M - - - 2.36 M 2.36 M 2.36 M 2.36 M 57.7 M 57.7 M 57.7 M 57.7 M

Retained Earnings

-78 M -85.5 M -415 M -413 M -411 M -411 M -370 M -366 M -417 M -403 M -382 M -357 M -337 M -315 M -315 M -315 M -315 M -259 M -259 M -259 M -259 M -203 M -203 M -203 M -203 M -173 M -173 M -173 M -173 M -148 M -148 M -148 M -148 M -131 M -131 M -131 M -131 M -116 M -116 M -313 M -313 M -110 M -281 M -281 M -281 M -234 M -234 M -234 M -234 M -227 M -227 M -227 M -227 M

Total Assets

122 M 117 M 9.96 M 12.4 M 18.8 M 28.4 M 31 M 83.4 M 40.3 M 55.7 M 78.5 M 102 M 119 M 94.8 M 94.8 M 94.8 M 94.8 M 98.6 M 98.6 M 98.6 M 98.6 M 125 M 125 M 125 M 125 M 39.5 M 39.5 M 39.5 M 39.5 M 38.1 M 38.1 M 38.1 M 38.1 M 69.5 M 69.5 M 69.5 M 69.5 M 2.98 M 2.98 M 112 M 112 M 5.27 M 146 M 146 M 146 M 190 M 190 M 190 M 190 M 258 M 258 M 258 M 258 M

Cash and Cash Equivalents

29.8 M 33.5 M 2.23 M 6.92 M 8.1 M 21.7 M 23.1 M 75.4 M 34.8 M 44.3 M 59.2 M 73.6 M 83 M 30.4 M 30.4 M 30.4 M 30.4 M 15.4 M 15.4 M 15.4 M 15.4 M 31.2 M 31.2 M 31.2 M 31.2 M 14.5 M 14.5 M 14.5 M 14.5 M 10.3 M 10.3 M 10.3 M 10.3 M 29.1 M 29.1 M 29.1 M 29.1 M 1.54 M 1.54 M 56.4 M 56.4 M 2.83 M 54.5 M 54.5 M 54.5 M 3.4 M 82.2 M 82.2 M 82.2 M 107 M 107 M 107 M 107 M

Book Value

88.8 M 78.5 M 3.52 M 5 M 7.36 M 11.6 M 29.4 M 79.1 M 27.1 M 41.1 M 60.7 M 85.2 M 104 M 76.1 M 76.1 M 76.1 M 76.1 M 68.3 M 68.3 M 68.3 M 68.3 M 120 M 120 M 120 M 120 M 30.8 M 30.8 M 30.8 M 30.8 M 16.1 M 16.1 M 16.1 M 16.1 M 31.4 M 31.4 M 31.4 M 31.4 M -475 K -475 K 109 M 109 M 1.63 M 135 M 135 M 135 M 176 M 176 M 176 M 176 M 174 M 174 M 174 M 174 M

Total Shareholders Equity

56.6 M -15.8 M 3.52 M -28.3 M 77.3 M -21.7 M 29.4 M 79.1 M 27.1 M 41.1 M 60.7 M 85.2 M 104 M 76.1 M 76.1 M 76.1 M 76.1 M 68.3 M 68.3 M 68.3 M 68.3 M 120 M 120 M 120 M 120 M 30.8 M 30.8 M 30.8 M 30.8 M 16.1 M 16.1 M 16.1 M 16.1 M 31.4 M 31.4 M 31.4 M 31.4 M -109 M -109 M 109 M 109 M -103 M 135 M 135 M 135 M -93.3 M 176 M 176 M 176 M 174 M 174 M 174 M 174 M

All numbers in USD currency